MRNA Earnings
Moderna next reports earnings on November 5, 2026. Track record: 4/4 beats.
Next Earnings In
Thursday, November 5, 2026
Current Price
$137.99
EPS Estimate
Earnings Per Share
-$1.20
-132.1% YoY
Trailing EPS
Last 12 months earnings
-$7.71
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
N/A
Margin: -141.4%
Analyst Rating
16 analysts
Analyst Sentiment
Hold16 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-06-30 | -$2.06 | -$1.97 | +4.3% | Beat |
| 2026-03-31 | -$3.88 | -$3.40 | +12.4% | Beat |
| 2025-12-31 | -$2.60 | -$2.11 | +18.9% | Beat |
| 2025-09-30 | -$2.18 | -$0.51 | +76.6% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | -$1.20 | $876.6M | -132.1% |
| Next Qtr(+1q) | -$1.87 | $685M | +8.2% |
| Current Year(0y) | -$8.43 | $2.1B | -16.5% |
| Next Year(+1y) | -$4.98 | $2.4B | +45.2% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
-$1.20
Revenue Estimate
$876.6M
Annual EPS Est.
-$8.43
-16.5% YoY
MRNA Earnings FAQ
When is MRNA's next earnings date?
Moderna (MRNA) is expected to report earnings on November 5, 2026. The consensus EPS estimate is -$1.20.
Does MRNA usually beat earnings estimates?
Moderna has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is MRNA's trailing EPS?
Moderna's trailing twelve-month EPS is -$7.71. This is calculated from the last four quarters of reported earnings.
What do analysts think about MRNA?
16 Wall Street analysts cover Moderna. The consensus rating is "Hold" with an average price target of $106.63, implying 22.7% downside from the current price.